Cart
sales@molnova.com
BAY32-5915
CAS No. 1571-30-8
BAY32-5915( 8-Hydroxyquinoline-2-carboxylic acid )
Catalog No. M27330 CAS No. 1571-30-8
BAY32-5915 is a selective inhibitor of IKKalpha.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | 36 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 78 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBAY32-5915
-
NoteResearch use only, not for human use.
-
Brief DescriptionBAY32-5915 is a selective inhibitor of IKKalpha.
-
DescriptionBAY32-5915 is a selective inhibitor of IKKalpha.
-
In VitroBAY32-5915 (50-200 μM) has no significant inhibitory effect on NF-κB activity in melanoma cells.
-
In Vivo——
-
Synonyms8-Hydroxyquinoline-2-carboxylic acid
-
PathwayImmunology/Inflammation
-
TargetIκB kinase (IKK)
-
RecptorPEGs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1571-30-8
-
Formula Weight189.17
-
Molecular FormulaC10H7NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (660.78 mM)
-
SMILESOC(=O)c1ccc2cccc(O)c2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
molnova catalog
related products
-
AZD3264
A novel IkB-kinase IKK2 inhibitor for treatment of inflammatory conditions such as asthma, chronic pulmonary obstructive disorder (COPD) and rheumatoid arthritis.
-
AS602868
A potent, selective and ATP-competitive inhibitor of IKK2 with IC50 of 60 nM and Ki of 20 nM.
-
MRT67307 HCl
MRT67307 is a kinase inhibitor of TBK1 MARK1-4 IKKε and NUAK1 (IC50: 19 27-52 160 and 230 nM respectively).
